Preliminary results of an intravitreal dexamethasone implant (Ozurdex®) in patients with persistent diabetic macular edema

BACKGROUND: To evaluate the efficacy and safety of an intravitreal dexamethasone implant (Ozurdex®; Allergan Inc, Irvine, CA, USA) in patients with persistent diabetic macular edema (DME) over a 6-month follow-up period. METHODS: Seventeen patients (20 eyes) affected by DME were selected. The mean a...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Pacella, Elena, Vestri, Anna Rita, Muscella, Roberto, Carbotti, Maria Rosaria, Castellucci, Massimo, Coi, Luigi, Turchetti, Paolo, Pacella, Fernanda
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2013
Teme:
Methodology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3720664/
https://ncbi.nlm.nih.gov/pubmed/23901252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S48364
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items